~," The importance of factors within hemolysate in modulating oxyhemoglobin (oxyHb)-induced contraction was examined in an in vitro model of rabbit basilar arteries. When the basilar arteries were exposed to purified oxyHb alone, the contractile response observed was significantly weaker than that seen in arteries exposed to hemolysate containing an equal concentration of oxyHb. In order to delineate the nature of the factors within hemolysate that facilitate contraction, hemolysate was fractionated, and various components were tested individually for their ability to elicit this effect. A low-molecular-weight fraction of hemolysate, ranging from 0.5 to 2.0 kD, elicited only a mild contraction. However, when this fraction was combined with purified oxyHb, the contractile response was comparable in magnitude to that of unfractionated hemolysate. These studies confirm that purified oxyHb is capable of inducing contraction in vitro. The data also demonstrate that oxyHb elicits a significantly weaker contraction than does hemolysate. In addition, the results suggest that lowmolecular-weight components in hemolysate (in the 0.5-to 2.0-kD range), while incapable of inducing a potent contraction alone, may act in concert with oxyHb to elicit the vasoconstriction seen following subarachnoid hemorrhage.
C
EREBRAL vasospasm represents the major cause of morbidity following subarachnoid hemorrhage (SAH). Converging lines of evidence suggest that products released during the breakdown of erythrocytes are important in the development of vasospasm. 6,r3-r5 In particular, oxyhemoglobin (oxyHb) has been identified as a potent spasmogen, with a central role in the pathogenesis of vasospasm. 4,6A6,2~ It is unclear, however, whether oxyHb alone or a combination of oxyHb and other factors released from the subarachnoid clot is responsible for the pathological vasoconstriction. In support of the latter possibility, several studies have indicated that the contractile response induced by oxyHb may be weaker than that elicited by other vasoactive agents in vitro. <23 One hypothesis, therefore, is that factors within hemolysate elicit vasoconstriction independently of oxyHb. Conversely, it is possible that nonhemoglobin factor(s) in hemolysate facilitate the vasoconstriction induced by oxyHb. The present studies were designed to examine the importance of factors within hemolysate in the production of contraction in an in vitro model using rabbit basilar arteries.
Materials and Methods

Basilar Artery Preparation and Tension Recording
Twenty-seven male New Zealand White rabbits, each weighing 2.8 to 3.8 kg, were anesthetized by intramuscular injection of ketamine (Ketaset, 50 mg/kg) and xylazine (Rompun, 10 rag/ kg), paralyzed with intravenous pancuronium bromide (0.08 my,/ kg), and ventilated with a dual-phase control respirator. The animals were perfused intracardially at room temperature, while the heart was still beating, with 100 ml of oxygenated (95% 02/5% CO2) modified Krebs' solution (MKS) containing (in raM): NaC1 120; KCI 4.5; MgSO4 1.0; NaHCO3 27.0; KHzPQ 1.0; CaCI 2 2.5; and dextrose 10.0. The brains were then rapidly removed, and basilar arteries were dissected free with the aid of a microscope. Four 3-ram basilar artery rings were prepared from each animal according to established methods. 4 Each ring was placed in an isometric tension set-up, suspended between two L-shaped, silicon-coated rods in an organ bath (10 ml working volume). The MKS was bubbled with 95% 02/5% CO> 4 and 5 tzl of Antifoam B* was added to the organ bath to prevent foaming. Isometric tension was recorded using a force-displace-ment transducer, a polygraph, and a chart recorder for later analysis.t The preparations were allowed to equilibrate at 37~ for 60 minutes prior to each experiment, and the resting tension was adjusted to 4013 mg. The in vitro responses of the basilar artery rings to the addition of hemolysate or oxyHb were compared to a standard challenge of 40 mM KCI. The KC1 challenge elicited a contraction defined as 100% for the purposes of this study. The integrity of endothelium was confirmed by observing vasodilation following the application of acetylcholine (10 -7 to 10 -4 M) in vessels preconstricted with serotonin (5-HT, 10 -6 M).
During experiments analyzing the effects of fractionated hemolysate, the 5-HT2 receptor blocker ketanserin (1 ~M) was added to the organ bath to reduce the effect of endogenous 5-HT within the hemolysate.
Preparation of Hemolysate and Oxyhemoglobin
The arterial blood collected from each rabbit was centrifuged at 800 G for 5 minutes, and the supernatant was discarded. The erythrocyte fraction was washed three times with MKS (volume of the MKS:blood ratio > 5:1). The erythrocytes were then lysed by four freeze/thaw cycles. Following a 1:1 dilution with MKS, the erythrocytes were centrifuged at 6000 G for 30 minutes, and the supernatant (hemolysate) was collected.
The oxyHb was prepared by column chromatography of the hemolysate, using a diethylaminoethyl-Sephadex G-50 column,~: as described previously? The oxyHb was eluted through the column with Tris buffer (0.05 M Tris, pH 7.6). The oxyHb/ Tris solution was then concentrated and purified using a 30-kD pore-size filter.w This solution was diluted with MKS (5 X volume), and the filtration/dilution process was repeated twice. Hemoglobin concentration was then measured using the cyanmethemoglobin method? Each sample was analyzed spectroscopically, 3 and was found to contain at least 98% oxyHb. Examples of the spectrophotometric traces of the purified oxyHb samples are shown in Fig. l .
Molecular weight fractionation of the hemolysate was performed with the Omegacell filter system (pore sizes 8 and 2 kD). Fractions containing hemolysate components of less than 8 kD and less than 2 kD were obtained by filtration under pressure using nitrogen gas (50 psi). To exclude hemolysate components of less than 0.5 kD, the hemolysate fractions were dialyzed][ against an aqueous solution, at least 160 times the volume of hemolysate. The dialysate was changed four times over 3 hours during this procedure. The samples were then dialyzed against oxygenated MKS for 3 hours. All fractionation and dialysis procedures were performed at 4~
Drug Preparation
Stock solutions of 5-HT hydrochloride and acetylcholine were made by dissolving the drugs in distilled water. Ketanserin was dissolved in HEPES (4-(2-hydroxyethyl)-l-piperazine ethanesulfonic acid) buffer. The drugs were diluted further in t Force-displacement transducer, Model FF03D, and polygraph, Model 79D, manufactured by Grass Instruments, Quincy, Massachusetts; chart recorder, Model 3418, supplied by Soltec Corp., Sun Valley, California.
:~ Diethylaminoethyl-Sephadex G-50 column manufactured by Sigma Chemical Co., St. Louis, Missouri.
w Omegacell filter supplied by Filtron Technology, Northborough, Massachusetts.
[[ Spectra/Por CE Molecularporous Dialysis Membrane manufactured by Spectrum, Houston, Texas.
FIG. 1. Absorption spectra of purified oxyhemoglobin (oxyHb) and freshly prepared hemolysate. In this example, the hemoglobin absorption spectrum of a purified oxyHb solution maintained at 4~ for 3 weeks (upper trace) was compared with that of freshly prepared hemolysate (lower trace). Both spectra demonstrate peaks at 540.5 and 576.0 nm, typical of oxyHb. Methemoglobin (630-nm peak on absorption spectrum) was not detected in any of the purified oxyHb or hemolysate samples.
MKS before use so that volumes of less than 0.2 ml were added to the organ baths.
Statistical Analysis
The selection of rings for comparison from each group of four basilar artery rings was based on similar magnitudes of vascular responses to KC1, 5-HT, and acetylcholine. When there was no significant difference between these samples, a set of consecutive rings was selected. Within each set of basilar artery rings, the assignment to treatment groups was performed randomly. Dose-response curves were evaluated by a two-way analysis of variance and the Bonferroni test. A p value of less than 0.05 was considered to be statistically significant.
Results
Responses to KCI, 5-HT, and Acetylcholine
The contractile responses to KCI and 5-HT were examined in all basilar artery rings at the start of each experiment. The application of 40 mM KC1 elicited a rapid, potent contractile response, which was defined as 100% for the purpose of calibration. Following removal of the KCI, the tension returned rapidly to baseline. Subsequent application of 5-HT (10 -6 M) resulted in a biphasic response, consisting of an initial rapid contraction followed by a slower tonic response. The mean tonic contraction elicited by 5-HT in 18 specimens was 24.6% _+ 5.1% ( _ standard error of the mean) of that induced by 40 mM KC1. To test for the presence of endothelium-derived relaxing factor in the ring preparation, acetylcholine (10 -7 to 10 -4 M) was added to the organ bath in the presence of a tonic 5-HTinduced contraction. Acetylcholine reversed the 5-HTinduced contraction in a dose-dependent manner, indicating that endothelium-dependent responses are retained in this preparation (Fig. 2) .
Comparison of Contraction Induced by Hemolysate and OxyHb
Eleven basilar arteries exposed to purified oxyHb exhibited weak contractile responses. The contractile re-Fro. 2. Graph showing the effect of acetylcholine (ACh) on serotonin (5-HT)-induced contraction. Eighteen basilar artery rings were preconstricted with 5-HT (10 -6 M). After a stable contraction was achieved, increasing concentrations of acetylcholine (10 -7 tO 10 -4 M) were added to the organ bath, and the resulting change in tone (A tension) was recorded. Acetylcholine elicited a dose-dependent relaxation. Contraction induced by 5-HT alone was defined as 100%. Values are expressed as mean + standard error of the mean.
sponse was dose-dependent from 10 -8 to 10 -4 M oxyHb. However, at concentrations above 10 -4 M, oxyHb did not elicit further contraction. In contrast, 11 basilar arteries treated with whole hemolysate demonstrated a potent, dose-dependent contractile response.
When the oxyHb concentrations within the hemolysate were calculated and compared to similar concentrations of purified oxyHb, the difference in the contractile effect was substantial at higher doses. Figure 3 left presents an example of the responses of rabbit basilar arteries to purified oxyHb and whole hemolysate. The quantitative results of this series of experiments are illustrated in Fig. 3 right. The maximum mean contraction induced by oxyHb (24.7% ___ 6.0% of that elicited by KCI) was significantly lower than that induced by hemolysate (132.8% • 2.2%).
Effects of Fractionated Hemolysate
Hemolysate obtained from rabbit blood was fractionated, and a fraction containing components of less than 8 kD in size was examined. Five basilar artery rings exposed to incremental concentrations of this fraction demonstrated only minor contractile responses (Fig. 4 left). In contrast, the five rings treated with a combination of the hemolysate fraction and purified oxyHb (at concentrations appropriate to the corresponding concentrations of hemolysate) exhibited a potent contraction (p < 0.05, compared with hemolysate alone). The magnitude of the contraction elicited by the combination was similar to that seen in five rings treated with whole hemolysate.
Similar results were obtained when the hemolysate fraction containing components smaller than 2 kD was tested. Treatment with this fraction in six specimens elicited only a mild contraction. When it was applied together with purified oxyHb a powerful contractile re- sponse was induced in six rings (Fig. 4 center) . In the experimental series examining the hemolysate fractions containing components of less than 2 kD and 8 kD in size, basilar artery rings were pretreated with ketanserin (10 -6 M) in order to block the potential contribution of endogenous 5-HT.
A final hemolysate fraction with constituents ranging from 0.5 to 2.0 kD was tested for its constrictor effects. This fraction was found to be a weak constrictor by itself (Fig. 4 right) . When a combination of this hemolysate fraction and oxyHb was applied, a potent contraction was induced with a magnitude similar to that elicited by the combination of the 2-kD fraction and oxyHb.
Discussion
The causative agent(s) of spastic vascular constriction after SAH has remained elusive despite intensive investigation. A number of vasoactive substances have been found in the subarachnoid clot, and there is accumulating evidence implicating oxyHb as the primary vasoconstrictor responsible for the development of vasospasm. 11-13,15a8 There is also evidence from in vitro studies, however, that oxyHb alone may not be capable 4 2 q of eliciting such a strong constrictor response., -One possible explanation for this discrepancy is that in vitro models do not replicate in vivo conditions where arteries are exposed to high concentrations of oxyHb for very long periods. 6 However, the timing of the vasospasm corresponds to the peak of erythrocyte lysis (both occur on Day 3), 17 arguing against the hypothesis that prolonged exposure is required for oxyHb-induced vasoconstriction. With regard to the possibility that a high concentration of oxyHb around arteries after SAH (up to 3 • 10 -3 M) is capable of inducing potent vasoconstriction, the present studies indicate that such high concentrations of oxyHb do not by themselves elicit a strong contractile response in vitro.
Concern over the possible vasoconstrictor effects of contaminants within preparations of partially purified hemoglobin has been the focus of recent discussion. 5'8'1~ For example, incompletely purified, stroma-free hemoglobin has been found to increase aortic pressure at a rate six times greater than hemoglobin purified by high-performance liquid chromatography? In addition, Lang, et al.,5 have reported that hemoglobin obtained by crystallization elicited potent coronary vasoconstriction, but that hemoglobin obtained through ultrafiltration did not. Furthermore, hemoglobin purified by adenosine triphosphate-agarose-affinity chromatography was significantly less potent as a vasoconstrictor than that prepared by a large-volume ultrafiltration technique (molecular weight 30 to 100 kD). z2 Such differences may, in part, explain the discrepancy in the results of Macdonald, et at., 7 and Mayberg, et aL 9 (both studies in which relatively impure preparations of oxyHb were used), and those of Boullin, et al.,1 who used oxyHb purified via column chromatography. The former two groups observed potent oxyHb-induced constriction, while the latter concluded that oxyHb alone is not capable of causing significant vasoconstriction. It is possible, therefore, that impurities within the oxyHb may confound the analysis of oxyHb-induced constriction.
Differences between species may be partly responsible for the variability described in the constrictive potency of hemoglobin. A number of studies suggest that oxyHb is the major vasoconstrictor component in hemolysate.ll 13,15.1s,~u Tanishima,1, for example, observed that canine cerebral arteries are equally responsive to oxyHb and hemolysate. The results of the present studies differ from this finding; in the in vitro rabbit basilar artery model, purified oxyHb was found to elicit a weak contractile response when compared to preparations with whole hemolysate. Differences among species in the vascular responses to oxyHb have been suggested previously? ,2~,23 In canine basilar arteries the maximum contraction elicited by oxyHb has been reported to be 40% to 66% of that induced by KC1, 4A921 and in monkey cerebral arteries oxyHbinduced contraction was found to be 70% of that induced by KC1. 21 In contrast, in rabbit basilar arteries oxyHb induced less than 20% of the contraction elicited by KCI. 4 The results from the present studies, in which oxyHb-induced contraction was 24.7% of the KC1 response, compare favorably with the latter series? When compared to a maximum 5-HT response, the relative contraction induced by oxyHb has been found to be smaller in human cerebral arteries than in those obtained from dogs or rabbits. 23 Therefore, it is plausible that, in human cerebral arteries undergoing vasospasm, factors other than oxyHb play an important role in the development of potent vasoconstriction. The model utilized in the present series is well suited for the study of the contribution of such factors.
The present studies indicate that oxyHb alone is insufficient to elicit the degree of vasoconstriction seen with whole hemolysate. This finding suggests two possible mechanisms: vasoactive factors within hemolysate independently augment the degree of vasoconstriction; and/or factors in hemolysate facilitate the action of oxyHb on the vessels. The presence of ketanserin, a selective 5-HT 2 receptor antagonist, in the hemolysate argues against the participation of 5-HT as an independent vasoconstrictor in this model. It is still possible, however, that 5-HT may act through 5-HTt receptors. 16 The effects of vasoconstrictors with a very low molecular weight, such as prostaglandin F2a (354 D) and 5-HT (176 D), have been reduced in the present studies by dialysis of components of less than 0.5 kD. In support of the second mechanism, possible hemolysate fractions of less than 8 kD, less than 2 kD, and between 0.5 and 2 kD were incapable of producing a strong contraction alone but, when combined with the appropriate concentration of oxyHb, elicited a very potent contractile response. Taken together, these results suggest that hemolysate contains at least one factor, ranging from 0.5 kD to 2 kD, that is a poor constrictor by itself but that interacts with oxyHb to produce a potent vasoconstrictor response. Although the identity of such a factor remains unknown, the current model system represents an ideal method with which to characterize it. The elucidation of the basic mechanisms by which oxyHb and other possible factors elicit vasoconstriction is essential to the development of effective measures to treat cerebral vasospasm.
